For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings
Philippa M Musoke, Pamela Fergusson
The American Journal of Clinical Nutrition  vol: 94  issue: 6  first page: 1716S  year: 2011  
doi: 10.3945/ajcn.111.018374

2. High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study
Steve Innes, Mark F Cotton, Richard Haubrich, Maria M Conradie, Margaret van Niekerk, Clair Edson, Helena Rabie, Sonia Jain, Xiaoying Sun, Ekkehard W Zöllner, Stephen Hough, Sara H Browne
BMC Pediatrics  vol: 12  issue: 1  year: 2012  
doi: 10.1186/1471-2431-12-183

3. Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study
Denise L Jacobson, Kunjal Patel, George K Siberry, Russell B Van Dyke, Linda A DiMeglio, Mitchell E Geffner, Janet S Chen, Elizabeth J McFarland, William Borkowsky, Margarita Silio, Roger A Fielding, Suzanne Siminski, Tracie L Miller
The American Journal of Clinical Nutrition  vol: 94  issue: 6  first page: 1485  year: 2011  
doi: 10.3945/ajcn.111.020271

4. Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
Steve Innes, Louvina van der Laan, Peter L. Anderson, Mark Cotton, Paolo Denti
Antimicrobial Agents and Chemotherapy  vol: 62  issue: 11  year: 2018  
doi: 10.1128/AAC.00761-18

5. Lipodystrophy among HIV‐infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
Thereza Piloya, Sabrina Bakeera‐Kitaka, Adeodata Kekitiinwa, Moses R Kamya
Journal of the International AIDS Society  vol: 15  issue: 2  year: 2012  
doi: 10.7448/IAS.15.2.17427

6. Fine needle aspiration of breast masses in HIV‐infected patients
Pam Michelow, Bruce J Dezube, Liron Pantanowitz
Cancer Cytopathology  vol: 118  issue: 4  first page: 218  year: 2010  
doi: 10.1002/cncy.20083

7. Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV
Junwei Su, Stephanie Shiau, Stephen M. Arpadi, Renate Strehlau, Megan Burke, Faeezah Patel, Louise Kuhn, Ashraf Coovadia, Michael T. Yin
Journal of Pediatric Gastroenterology and Nutrition  vol: 72  issue: 1  year: 2021  
doi: 10.1097/MPG.0000000000002907

8. Estimation of Intracellular Concentration of Stavudine Triphosphate in HIV-Infected Children Given a Reduced Dose of 0.5 Milligrams per Kilogram Twice Daily
Sherwin K. B. Sy, Steve Innes, Hartmut Derendorf, Mark F. Cotton, Bernd Rosenkranz
Antimicrobial Agents and Chemotherapy  vol: 58  issue: 2  first page: 1084  year: 2014  
doi: 10.1128/AAC.01717-13

9. Anthropometric Measurements and Lipid Profiles to Detect Early Lipodystrophy in Antiretroviral Therapy Experienced HIV-Infected Children in the Chapas-3 Trial
Victor Musiime, Adrian Cook, Joshua Kayiwa, Dorothy Zangata, Carol Nansubuga, Beatrice Arach, Julia Kenny, Priscilla Wavamunno, Justine Komunyena, Desiree Kabamba, Alice R Asiimwe, Grace Mirembe, George Abongomera, Veronica Mulenga, Adeodata Kekitiinwa, Cissy Kityo, Sarah A Walker, Nigel Klein, Diana M Gibb
Antiviral Therapy  vol: 19  issue: 3  first page: 269  year: 2014  
doi: 10.3851/IMP2695

10. Cardiovascular Complications in Children with HIV Infection
Amy Sims, Colleen Hadigan
Current HIV/AIDS Reports  vol: 8  issue: 3  first page: 209  year: 2011  
doi: 10.1007/s11904-011-0081-9

11. Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine
N Sawawiboon, O Wittawatmongkol, W Phongsamart, W Prasitsuebsai, K Lapphra, K Chokephaibulkit
International Journal of STD & AIDS  vol: 23  issue: 7  first page: 497  year: 2012  
doi: 10.1258/ijsa.2011.011348

12. Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks
Judith A. Aberg, Pablo Tebas, Edgar Turner Overton, Samir K. Gupta, Paul E. Sax, Alan Landay, Ron Falcon, Robert Ryan, Guy De La Rosa
AIDS Research and Human Retroviruses  vol: 28  issue: 10  first page: 1184  year: 2012  
doi: 10.1089/aid.2011.0327

13. Metabolic complications and treatment of perinatally HIV‐infected children and adolescents
Linda Barlow‐Mosha, Allison Ross Eckard, Grace A McComsey, Philippa M Musoke
Journal of the International AIDS Society  vol: 16  issue: 1  year: 2013  
doi: 10.7448/IAS.16.1.18600

14. High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?
Grace Kisitu, Veronika Shabanova, Fairuzi Naiga, Mary Nakagwa, Adeodata R. Kekitiinwa, Peter J. Elyanu, Elijah Paintsil
HIV Medicine  vol: 25  issue: 2  first page: 262  year: 2024  
doi: 10.1111/hiv.13570

15. Rapidly growing lipoma as the syndrome of lipodystrophy in HIV-infected child
Katarzyna Mazur-Melewska, Tomasz Macedulski, Sebastian Moryciński, Anna Mania, Ewa Trejster, Magdalena Figlerowicz, Justyna Pohland, Przemysław Mańkowski, Wojciech Służewski
Open Medicine  vol: 7  issue: 6  first page: 753  year: 2012  
doi: 10.2478/s11536-012-0068-y

16. HIV and antiretroviral therapy-related fat alterations
John R. Koethe, Claire Lagathu, Jordan E. Lake, Pere Domingo, Alexandra Calmy, Julian Falutz, Todd T. Brown, Jacqueline Capeau
Nature Reviews Disease Primers  vol: 6  issue: 1  year: 2020  
doi: 10.1038/s41572-020-0181-1